How might feeling awe impact our well-being? Check out CPCR postdoc Dr. Sean Goldy's (Sean Goldy) piece in Johns Hopkins Medicine's CLOSLER to find out! closler.org/passion-in-the…

Congratulations to Associate Center Director Dr. Albert Garcia-Romeu (AlChemical77) for being a recipient of the Rosalind Franklin Society (Rosalind Franklin Society) Awards in Science, which recognizes outstanding peer-reviewed research by women and underrepresented minorities in STEM. Dr.

Dr. Adam Levin and CPCR faculty Dr. Alan Davis wrote a piece in Psychiatric Times (Psychiatric Times) discussing findings from a follow-up study to our randomized controlled trial for depression and psilocybin therapy. They highlight the relationship between therapeutic relationship

Do you like listening to music? We are seeking individuals to participate in a research study looking at the effects of musical playlists on emotions, well-being, and brain function. Volunteers must be medically and psychiatrically healthy and must be able to travel to Johns

Researchers at Johns Hopkins University are seeking individuals with chronic low back pain and co-occurring depression to participate in a research study on the effects of psilocybin and whether or not it can help with chronic low back pain and co-occurring depression. Email us

CPCR Associate Center Director Dr. Albert Garcia-Romeu (AlChemical77) and colleagues recently published a paper on attitudes toward and willingness to use psychedelics for concussion recovery among athletes and sports staff. Check it out! journals.sagepub.com/doi/10.1177/20…

CPCR Director Dr. Frederick Barrett (Fred Barrett) and graduate student Nathan Heller published an article on the state of psychedelic neuroscience, including challenges and future steps. nature.com/articles/s4138…

The CPCR was a co-sponsor of the HOPE Summit 2024 this past weekend - an event focused on discussing psychedelic ethics and aims to identify ways to improve the field as a whole. Photo credits to Keisha Ray, PhD 😊 HOPE Johns Hopkins Berman Institute of Bioethics Practical Ethics

The Johns Hopkins Center for Psychedelic and Consciousness Research has recently created an inaugural PTSD Research Program devoted to investigating the safety and efficacy of psychedelic therapies in the treatment of Posttraumatic Stress Disorder, with one study currently

Dr. Fred Barrett (Fred Barrett) will be presenting at Psychedelics and Cannabis: Hype, Hope, and Harm next month at The Mathison Centre

It’s high time the field of psychedelic research move beyond the mystical experience construct (MEQ). While many critiques of the measure rest on misconceptions, persistent misunderstandings & psychometric limitations lead us to recommend transcending it.

How has the inclusion of ethnoracial minorities in psychedelics changed over time? A visual content story found on the JHPsychedelics Instagram page: instagram.com/p/C_dykwCyLpn/… .

‼️ New Paper ‼️ Commentary lead by Dr. Rebecca Ehrenkranz advocating for better systems to measure and report adverse events, and more balanced attention to the risks and benefits of psychedelics Rebecca Ehrenkranz, PhD, MPH Sunstone Therapies Sandeep Nayak David B. Yaden liebertpub.com/doi/10.1089/ps…

We are excited to welcome Dr. Zarmeen Zahid Dr. Zarmeen Zahid to the CPCR as a post-doctoral fellow! In her PhD she studied the role of synaptic plasticity in the mechanism of serotonergic psychedelics. Here, she will be furthering her interests in psychedelics both clinically and

New paper published in JAMA Psychiatry: A meta-analysis of adverse events in trials of classic psychedelics suggests an overall favorable safety profile. However, serious adverse events, while rare, did occur. It highlights ways to improve the detection and reporting of adverse events